Scientific Programme
Topics and Highlights
Ge-68/Ga-68 generators
Theory and practice of generator post-processing
Automation in generator elution and labelling including GMP aspects
Specific activities, dosimetry, breakthrough, waste
New ligands for Ga-68
Chemistry of new Ga-68 labelled tracers
Pre-clinical evaluation of new Ga-68 tracers
Regulatory issues related to investigational radiopharmaceuticals
Large scale production of therapeutic radionuclides (Lu-177, Y-90 and other trivalent therapeutic radiometals)
Chemistry of new Lu-177 labelled tracers
Pre-clinical evaluation of new Lu-177 tracers
Ga-68 imaging in clinical practice – worldwide experience (Europe, Asia, South America, Africa)
Ga-68 for imaging bone metastases
Ga-68 for infection imaging
Ga-68-labeled PET tracers for studying pathophysiological properties of the P-glycoprotein
Ga-68 in clinical practice - new tracers and new indications
Current progress and novel developments in ongoing research projects
Milestones of Peptide Receptor Radionuclide Therapy (PRRNT)
Milestones of PRRNT - clinical applications and future developments
Selection criteria for PRRNT
PRRNT – Worldwide clinical experience
Diagnosis and Follow-up after PRRNT using Receptor PET/CT
The importance of quantitative molecular imaging and automated image analysis
Dosimetry and Radiation Protection - Practical issues
THERANOSTICS: From molecular imaging using Ga-68 labeled tracers and PET/CT to personalized therapy
The programme will include lectures covering all aspects of Ga-68 and PRRNT and recent advances in this area. There are free oral paper sessions and poster presentations. There will be ample space and opportunity for discussions during the meeting and there will be no parallel sessions.